Literature DB >> 11722627

CD4+CD25+ regulatory cells in acquired MHC tolerance.

E H Field1, D Matesic, S Rigby, T Fehr, T Rouse, Q Gao.   

Abstract

Tolerance to self-antigens is an ongoing process that begins centrally during T-cell maturation in the thymus and continues throughout the cell's life in the periphery by a network of regulated restraints. Remaining self-reactive T-cells that escape intrathymic deletion may be silenced within the peripheral immune system by specialized regulatory CD4+ cells. By analogy, regulatory CD4+ cells that control immunity to "acquired self" should arise in circumstances where the immune system acquires tolerance to foreign MHC, such as the tolerance that develops following the exposure to foreign MHC antigens during the neonatal period. We have used this classic model of neonatal tolerance to examine the role of regulatory CD4+ cells in acquired tolerance to disparate class I and class II MHC. Adoptive transfer of unfractionated but not CD4+-depleted spleen cells from neonatal tolerant mice into SCID recipients inhibited skin graft rejection by immunocompetent CD8+ T cells. Using 5-bromo-2'-deoxyuridine incorporation, standard cytotoxic T-lymphocyte assays, short-term interferon-gamma ELISPOT, and intracellular FACS analysis to study CD8+ T-cell effector function, we demonstrated that neonatal tolerant mice contain CD4+CD25+ cells that suppress the development of anti-donor CD8+ T-cell responses in vitro. We conclude that regulatory CD4+CD25+ cells initiate and/or maintain tolerance by preventing the development of CD8+ T-cell alloreactivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722627     DOI: 10.1034/j.1600-065x.2001.1820108.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  8 in total

1.  Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression.

Authors:  Elizabeth H Field; Katarina Kulhankova; Mohamed E Nasr
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.

Authors:  Ling Weng; Julian Dyson; Francesco Dazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

3.  Heterogeneity in the CD4 T Cell Compartment and the Variability of Neonatal Immune Responsiveness.

Authors:  Becky Adkins
Journal:  Curr Immunol Rev       Date:  2007-08

4.  The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN.

Authors:  Yan-Ying Wang; Xiao-Ye He; Ying-Yun Cai; Zhi-Jun Wang; Shao-Hua Lu
Journal:  Target Oncol       Date:  2011-05-25       Impact factor: 4.493

5.  Heparin affects the induction of regulatory T cells independent of anti-coagulant activity and suppresses allogeneic immune responses.

Authors:  Y Kashiwakura; H Kojima; Y Kanno; M Hashiguchi; T Kobata
Journal:  Clin Exp Immunol       Date:  2020-07-15       Impact factor: 4.330

6.  Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens.

Authors:  Shannon J Opiela; Robert B Levy; Becky Adkins
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

7.  Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.

Authors:  Jinpu Yu; Jingyan Sun; Shizhen Emily Wang; Hui Li; Shui Cao; Yizi Cong; Juntian Liu; Xiubao Ren
Journal:  Clin Dev Immunol       Date:  2011-10-24

Review 8.  Understanding the role of the kynurenine pathway in human breast cancer immunobiology.

Authors:  Benjamin Heng; Chai K Lim; David B Lovejoy; Alban Bessede; Laurence Gluch; Gilles J Guillemin
Journal:  Oncotarget       Date:  2016-02-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.